U.S. Transportation Stock News

If you are wondering whether Capri Holdings trades at a fair price or offers value, it helps to start with how the market has treated the stock recently and what that says about expectations. The share price closed at US$18.51, with a 0.2% gain over the last week, a decline of 5.7% over the last month, a decline of 24.1% year to date, a 2.2% gain over the last year, a decline of 48.7% over three years, and a decline of 65.6% over five years. Recent coverage around Capri Holdings has focused...

Maximus (NYSE:MMS) amended its credit agreement to add $325 million to its existing term B loans. The company plans to use the new debt for share repurchases, working capital, and repayment of existing debt. Maximus, trading at $61.93, is taking on additional term B loan financing that directly affects how it allocates capital between shareholders and creditors. The move comes after the stock declined 28.4% year to date and 13.1% over the past year, with a 22.0% decline over three years and...

HomesToLife (HTLM) has opened 2026 with Q1 revenue of US$92.5 million and basic EPS of US$0.04. Trailing twelve month revenue sits at US$390.9 million and EPS at US$0.19, framing a business that is currently earning at a higher run rate than any single recent quarter. The company has seen revenue move from US$335.1 million and EPS of US$0.09 on a trailing basis in Q4 2024 to US$390.9 million and EPS of US$0.19 by Q1 2026. This has occurred alongside a trailing net profit margin of 4.5% and...

World Health Organization recommends Regeneron’s maftivimab for priority evaluation in clinical trials for the current Bundibugyo ebolavirus outbreak. Maftivimab is a component of Inmazeb, which is already approved for Zaire ebolavirus treatment. The recommendation positions Regeneron Pharmaceuticals (NasdaqGS:REGN) within an active emergency response affecting multiple African countries. Regeneron Pharmaceuticals, traded as NasdaqGS:REGN, is widely known for its antibody platforms and...

In late May 2026, Safe Pro Group Inc. announced progress in its AI-powered threat detection collaboration with Lantronix, integrating Safe Pro’s algorithms into Lantronix’s Open-Q System-on-Module platform for real-time edge processing across drones and autonomous systems. This work, already tied to Qualcomm-based platforms and U.S. Army Short Range Reconnaissance drones under a Master Services Agreement, underscores Lantronix’s role in enabling NDAA-compliant, on-device AI for defense and...

QTREX Quantum Ltd., formerly Inspira Technologies Oxy B.H.N. Ltd., recently agreed to a US$10,000,000 private placement of 6,666,667 ordinary shares and earlier announced a US$580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems. Together with the upcoming ticker change to “QTEX” on the Nasdaq Capital Market, these moves highlight fresh institutional interest and early clinical adoption of the ART100 platform by a...

Securities class action lawsuit filed against Zoetis (NYSE:ZTS) and certain executives alleging misleading statements about product safety and demand in the Companion Animal division. Claims focus on disclosures around veterinarian adoption, competitive pressures, and demand trends for key Companion Animal products. The suit alleges that weakening prescriptions, new competition, and slowing demand were not fully communicated before guidance cuts. Zoetis, trading at $77.69, is facing this...

FDA has granted Priority Review for BridgeBio Pharma's BBP-418 for limb-girdle muscular dystrophy type 2I/R9. If approved, BBP-418 could become the first and only therapy for LGMD2I/R9 and the first treatment for any form of LGMD. The Priority Review follows acceptance of BridgeBio's NDA and is tied to plans for a near-term commercial launch. For investors following BridgeBio Pharma (NasdaqGS:BBIO), this regulatory step sits alongside a share price of $66.26, a 3-year return of around 4x,...

Humacyte recently reported research from its acellular tissue engineered vessel (ATEV) program showing long-term structural integrity and self-repair after years of repeated dialysis cannulation, alongside reduced infection susceptibility versus ePTFE grafts, and confirmed that top-line Phase 3 V012 dialysis access results are scheduled for release on June 11, 2026. Together with ongoing late-stage trials and an approved vascular trauma indication, the ATEV’s self-repair profile highlights...

Buckle (BKE) opened Q1 2027 with revenue of US$288.7 million and basic EPS of US$0.93, setting the tone against a trailing twelve month backdrop of US$1.3 billion in revenue and basic EPS of US$4.40. Over the past year, the company has seen quarterly revenue move from US$272.1 million in Q1 2026 to US$399.1 million in Q4 2026 before landing at US$288.7 million in the latest quarter, while basic EPS ranged from US$0.70 to US$1.60 over the same stretch, giving investors a clear read on how top...

Willis Towers Watson (NasdaqGS:WTW) has announced new leadership appointments in its FINEX North America business to sharpen its cyber strategy. The moves include a new Head of Cyber and roles focused on executing cyber plans and deepening client engagement across North America. The changes come as AI driven risk, governance concerns, and cyber threats draw increased attention across the insurance and risk advisory sector. For investors following NasdaqGS:WTW, these appointments sit at the...

Earlier in May 2026, Netskope announced an integration between its Netskope One AI Security platform and Anthropic’s Claude Compliance API, enabling enterprises to apply unified visibility, policy enforcement, data protection, and compliance controls across their Claude Enterprise deployments in real time. This integration highlights how closely cloud security vendors and AI platform providers are now working together to embed governance directly into everyday AI workflows, reducing manual...

SentinelOne (S) just posted its Q1 2027 numbers, reporting revenue of US$276.7 million, a loss of US$76.2 million on a net income basis, and basic EPS of US$0.23 loss, with trailing twelve month revenue at about US$1.0 billion and a TTM net loss of US$318.7 million or EPS of US$0.96 loss. Over recent quarters the company has seen revenue move from US$229.0 million in Q1 2026 through US$271.2 million in Q4 2026 to US$276.7 million in Q1 2027. Quarterly basic EPS has ranged from a loss of...

UiPath (PATH) has reported Q1 2027 revenue of US$418.4 million and basic EPS of US$0.04, setting a clear marker for how the automation specialist is currently converting top line into profit. The company has seen quarterly revenue move from US$356.6 million in Q1 2026 to US$418.4 million in Q1 2027, while basic EPS shifted from a loss of US$0.04 to a profit of US$0.04. This points to a materially different earnings profile compared with the same period last year. For investors, the key...

HealthEquity’s Q1 2027 earnings snapshot HealthEquity (HQY) opened its Q1 2027 report with total revenue of US$354.6 million and basic EPS of US$0.82, supported by net income of US$69.4 million. Over the past six quarters, revenue has moved from US$311.8 million in Q4 2025 to US$354.6 million in Q1 2027, while quarterly basic EPS has ranged from US$0.30 to US$0.82, and trailing twelve month EPS has reached US$2.70 on revenue of about US$1.3 billion. With trailing net profit margins reported...

If you are wondering whether Kennametal at around US$32.80 still offers value, the starting point is understanding what the current price already implies about the business. The stock is up 13.1% year to date and 56.7% over the past year, even though it has fallen 9.1% in the last week and 14.9% over the past month. This can change how investors view both its potential and its risks. Recent coverage has focused on how Kennametal fits into broader themes in capital goods and industrial...

In late May 2026, Robinhood Markets launched “Agentic Trading” and an “Agentic Credit Card,” letting customers connect third‑party AI agents to dedicated brokerage and virtual card accounts that can autonomously trade equities and make purchases within user‑defined limits and guardrails. The move effectively brings institutional‑style automated tools, such as portfolio construction, rebalancing and rule‑based strategies via platforms like ChatGPT and Claude, directly to retail investors,...

DTE Energy (NYSE:DTE) and LG Energy Solution Vertech plan to deploy eight battery energy storage projects across Michigan. The partnership represents a planned US$1.6b investment in large scale battery infrastructure. The projects are intended to support Michigan’s grid reliability, clean energy goals, and growing data center power needs. DTE Energy (NYSE:DTE) is a regulated utility serving Michigan with electricity and natural gas, so grid reliability and long term capacity planning sit at...

Shein has accused PDD Holdings’ Temu platform of industrial-scale copyright infringement affecting thousands of product listings. Temu has withdrawn certain legal defenses related to the alleged infringements while simultaneously filing its own counterclaim against Shein. The dispute centers on intellectual property practices in fast fashion e-commerce and is ongoing, with potential implications for Temu’s global operations. PDD Holdings (NasdaqGS:PDD), parent of discount-focused...

T1 Energy (NYSE:TE) is now the focus of the new T-REX 2X Long TE Daily Target ETF, which offers 2x daily long exposure to the stock. The ETF launch introduces a leveraged trading vehicle tied directly to T1 Energy’s share price. This product highlights renewed investor attention as T1 Energy expands its US solar manufacturing footprint. T1 Energy operates in the clean energy space, with an emphasis on solar manufacturing in the US. The introduction of a dedicated 2x daily long ETF reflects...

Elastic FY 2026 earnings snapshot Elastic (ESTC) has wrapped up FY 2026 with Q4 revenue of US$450.7 million and basic EPS of US$4.18, while trailing twelve month EPS sits at US$3.49 on revenue of US$1.7 billion and net income of US$367.8 million. Over recent quarters, the company has seen revenue range from US$388.4 million in Q4 FY 2025 to US$450.7 million in Q4 FY 2026, with basic EPS moving from a loss of US$0.16 to a profit of US$4.18 as interim periods included both losses and modest...

Qiagen launched new digital PCR assays for Bundibugyo ebolavirus surveillance, expanding its infectious disease research tools. The assays are research use only and are designed to help laboratories and public health teams track the emerging outbreak. The release highlights Qiagen's focus on rapid support for global outbreak response workflows. For investors watching NYSE:QGEN, this move comes as the stock trades at $36.59. The share price is up 4.0% over the past week and 8.9% over the...

We wouldn't blame Acushnet Holdings Corp. ( NYSE:GOLF ) shareholders if they were a little worried about the fact that...

We'd be surprised if Palladyne AI Corp. ( NASDAQ:PDYN ) shareholders haven't noticed that the Co- Founder & CTO, Denis...